87 related articles for article (PubMed ID: 8151850)
1. Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study Group.
Lundgren JD; Phillips AN; Pedersen C; Clumeck N; Gatell JM; Johnson AM; Ledergerber B; Vella S; Nielsen JO
JAMA; 1994 Apr; 271(14):1088-92. PubMed ID: 8151850
[TBL] [Abstract][Full Text] [Related]
2. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
3. Survival of zidovudine-treated patients with AIDS compared with that of contemporary untreated patients. Italian Zidovudine Evaluation Group.
Vella S; Giuliano M; Pezzotti P; Agresti MG; Tomino C; Floridia M; Greco D; Moroni M; Visco G; Milazzo F
JAMA; 1992 Mar; 267(9):1232-6. PubMed ID: 1538560
[TBL] [Abstract][Full Text] [Related]
4. Zidovudine therapy, CD4+ and CD8+ counts are associated with a longer survival following AIDS onset.
Fiala M; Swartz J; Teklehaimanot S; Kermani V; Funnye AS; Sayre JW; Gornbein JA
Lymphology; 1997 Sep; 30(3):128-36. PubMed ID: 9313205
[TBL] [Abstract][Full Text] [Related]
5. Zidovudine and the natural history of the acquired immunodeficiency syndrome.
Moore RD; Hidalgo J; Sugland BW; Chaisson RE
N Engl J Med; 1991 May; 324(20):1412-6. PubMed ID: 2020297
[TBL] [Abstract][Full Text] [Related]
6. Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study Group.
Moore RD; Keruly J; Richman DD; Creagh-Kirk T; Chaisson RE
AIDS; 1992 Jul; 6(7):671-7. PubMed ID: 1503686
[TBL] [Abstract][Full Text] [Related]
7. Zidovudine therapy and health resource utilization in AIDS.
Moore RD; Hidalgo J; Bareta JC; Chaisson RE
J Acquir Immune Defic Syndr (1988); 1994 Apr; 7(4):349-54. PubMed ID: 8133446
[TBL] [Abstract][Full Text] [Related]
8. Early versus deferred zidovudine monotherapy: impact on AIDS-free time and survival in the multicenter AIDS cohort study.
Detels R; Muñoz A; Peng Y; Graham N; Mellors J; Phair J
Antivir Ther; 1997 Jan; 2(1):21-9. PubMed ID: 11322263
[TBL] [Abstract][Full Text] [Related]
9. Survival of patients receiving zidovudine before or after AIDS diagnosis: results of a German multicenter study. German AIDS Study Group.
Clin Investig; 1994 Jan; 72(2):111-6. PubMed ID: 8186655
[TBL] [Abstract][Full Text] [Related]
10. Survival differences in European patients with AIDS, 1979-89. The AIDS in Europe Study Group.
Lundgren JD; Pedersen C; Clumeck N; Gatell JM; Johnson AM; Ledergerber B; Vella S; Phillips A; Nielsen JO
BMJ; 1994 Apr; 308(6936):1068-73. PubMed ID: 7909698
[TBL] [Abstract][Full Text] [Related]
11. Changes in survival over time after a first episode of Pneumocystis carinii pneumonia for European patients with acquired immunodeficiency syndrome. Multicentre Study Group on AIDS in Europe.
Lundgren JD; Barton SE; Katlama C; Ledergerber B; González-Lahoz J; Pinching AJ; Proenca R; Hemmer R; Pedersen C; Phillips AN
Arch Intern Med; 1995 Apr; 155(8):822-8. PubMed ID: 7717790
[TBL] [Abstract][Full Text] [Related]
12. Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
Chaisson RE; Moore RD; Richman DD; Keruly J; Creagh T
Am Rev Respir Dis; 1992 Aug; 146(2):285-9. PubMed ID: 1362634
[TBL] [Abstract][Full Text] [Related]
13. Survival and medical intervention in southern Brazilian AIDS patients.
Santos B; Beck EJ; Peixoto MF
Int J STD AIDS; 1994; 5(4):279-83. PubMed ID: 7948159
[TBL] [Abstract][Full Text] [Related]
14. The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group.
Volberding PA; Lagakos SW; Grimes JM; Stein DS; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS; Phair JP; Mitsuyasu RT
JAMA; 1994 Aug; 272(6):437-42. PubMed ID: 7913730
[TBL] [Abstract][Full Text] [Related]
15. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group.
Spector SA; Gelber RD; McGrath N; Wara D; Barzilai A; Abrams E; Bryson YJ; Dankner WM; Livingston RA; Connor EM
N Engl J Med; 1994 Nov; 331(18):1181-7. PubMed ID: 7935655
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group.
Gallant JE; Moore RD; Richman DD; Keruly J; Chaisson RE
Arch Intern Med; 1994 Mar; 154(5):566-72. PubMed ID: 8122950
[TBL] [Abstract][Full Text] [Related]
17. Implications of generalists' slow adoption of zidovudine in clinical practice.
Markson LE; Cosler LE; Turner BJ
Arch Intern Med; 1994 Jul; 154(13):1497-504. PubMed ID: 8018005
[TBL] [Abstract][Full Text] [Related]
18. Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection: meta-analyses of the randomised evidence. HIV Trialists' Collaborative Group.
Lancet; 1999 Jun; 353(9169):2014-25. PubMed ID: 10376616
[TBL] [Abstract][Full Text] [Related]
19. Survival trends for patients with AIDS.
Lemp GF; Payne SF; Neal D; Temelso T; Rutherford GW
JAMA; 1990 Jan; 263(3):402-6. PubMed ID: 2294307
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of AIDS dementia complex in Europe. AIDS in Europe Study Group.
Chiesi A; Vella S; Dally LG; Pedersen C; Danner S; Johnson AM; Schwander S; Goebel FD; Glauser M; Antunes F
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jan; 11(1):39-44. PubMed ID: 8528731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
